Surrozen Ownership | Who Owns Surrozen?
Surrozen Ownership Summary
Surrozen is owned by 78.47% institutional investors, 3.18% insiders, and 18.36% retail investors. Column group is the largest institutional shareholder, holding 25.10% of SRZN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.30% of its assets in Surrozen shares.
SRZN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Surrozen | 78.47% | 3.18% | 18.36% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Column group | 810.09K | 25.10% | $11.62M |
| Tcg crossover management | 1.47M | 13.45% | $42.91M |
| Ra capital management | 602.63K | 7.06% | $7.76M |
| Boxer capital management | 766.32K | 7.00% | $22.32M |
| Millennium management | 731.14K | 6.68% | $21.30M |
| Vr adviser | 632.93K | 5.78% | $18.44M |
| Vanguard group | 319.24K | 3.72% | $7.21M |
| Braidwell lp | 396.10K | 3.62% | $11.54M |
| 5am venture management | 387.50K | 3.54% | $11.29M |
| Vestal point capital, lp | 338.61K | 3.09% | $9.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 810.09K | 20.85% | $11.62M |
| Acuta capital partners | 172.85K | 3.55% | $5.04M |
| 5am venture management | 387.50K | 3.13% | $11.29M |
| Boxer capital management | 766.32K | 2.93% | $22.32M |
| Tcg crossover management | 1.47M | 1.23% | $42.91M |
| Stempoint capital lp | 195.98K | 1.11% | $5.71M |
| Vr adviser | 632.93K | 0.69% | $18.44M |
| Euclidean capital | 87.70K | 0.65% | $2.55M |
| Vivo capital | 260.00K | 0.63% | $7.57M |
| Silverarc capital management | 144.25K | 0.43% | $4.20M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 1.47M | 1.23% | 1.47M |
| Boxer capital management | 766.32K | 2.93% | 350.17K |
| Vestal point capital, lp | 338.61K | 0.28% | 338.61K |
| Perceptive advisors | 229.39K | 0.13% | 229.39K |
| Ikarian capital | 173.11K | 0.41% | 107.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Stempoint capital lp | 195.98K | 1.11% | -423.79K |
| Nantahala capital management | - | - | -229.53K |
| Empery asset management, lp | - | - | -103.97K |
| Stonepine capital management | 33.01K | 0.39% | -80.63K |
| Schonfeld strategic advisors | - | - | -74.64K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 1.47M | 1.23% | 1.47M | $42.91M |
| Vestal point capital, lp | 338.61K | 0.28% | 338.61K | $9.86M |
| Perceptive advisors | 229.39K | 0.13% | 229.39K | $6.68M |
| Two sigma investments, lp | 39.48K | 0.00% | 39.48K | $1.15M |
| Vanguard fiduciary trust | 35.39K | 0.00% | 35.39K | $1.03M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -2.00 |
| Wolverine asset management | -281.00 |
| Citigroup | -1.06K |
| Ieq capital | -13.47K |
| Omers administration | -13.70K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 57 | 5.56% | 8,591,558 | 20.30% | 78 | 1.13% | 31 | -26.19% | 13 | 550.00% |
| Dec 31, 2025 | 13 | -62.86% | 888,511 | -81.65% | 10 | 0.32% | 12 | -20.00% | - | -100.00% |
| Sep 30, 2025 | 9 | -70.00% | 521,321 | -88.49% | 6 | 0.22% | 5 | -54.55% | 1 | -66.67% |
| Jun 30, 2025 | 30 | - | 4,529,305 | -16.85% | 53 | 0.24% | 11 | -38.89% | 3 | 50.00% |
| Mar 31, 2025 | 1 | - | 1,499,773 | 85.14% | 41 | 6.56% | 1 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 149.87K | 1.30% | 52.23K |
| Vanguard Institutional Extnd Mkt Idx Tr | 64.21K | 0.56% | - |
| Alger Life Sciences Innovation Composite | 63.63K | 0.55% | 7.21K |
| Alger LIfe Sciences Innovation Composite | 63.63K | 0.55% | 7.21K |
| Fidelity Extended Market Index | 26.61K | 0.23% | -116.00 |
| Extended Equity Market Fund E | 14.52K | 0.13% | 12.11K |
| Extended Equity Market Fund B | 14.52K | 0.13% | 12.11K |
| Blackrock Extended Mkt Fund CF | 14.52K | 0.13% | - |
| Extended Equity Market Fund K | 12.37K | 0.11% | -91.00 |
| BlackRock Extended Equity Market Fund K | 12.37K | 0.11% | -91.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 04, 2026 | Li Yang | Exec. Vice President, Research | Sell | $52.80K |
| May 04, 2026 | Williams Charles O | Chief Operating Officer | Sell | $67.87K |
| May 04, 2026 | Parker Craig C | Chief Executive Officer | Sell | $150.80K |
| Mar 23, 2026 | TCG Crossover GP II, LLC | - | Buy | $189.51K |
| Mar 24, 2026 | TCG Crossover GP II, LLC | - | Buy | $1.32M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | 44 | 2 |
| 2025 Q4 | 12 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 13 | 2 |
SRZN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools